Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed Dose Comparison in Platinum-Resistant Ovarian Cancer
NCT00109096Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of pemetrexed in ovarian cancer, primary peritoneal cancer (PPC), sponsored by Eli Lilly and Company. Started Jun 2005; status: completed.
02
Drugs
pemetrexed
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00109096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109096.